Catalyst Event

Samchundang Pharm Co Ltd (000250) · Other

From Akros SCHK HK-Korea Biotech Index (ASHKBIO)

5/11/2026, 12:00:00 AM

OtherSentiment: Negative

South Korea's Financial Supervisory Service (FSS) officially stated it is closely monitoring Samchundang Pharm following recent controversies over public disclosures and stock price volatility on 2026-05-11. The FSS also announced plans to issue new disclosure guidelines for bio-pharma companies by the end of June 2026, with an expected price impact of ≥10%.

Korean Translation

금융감독원, 공시 논란 및 주가 변동성과 관련하여 2026-05-11 삼천당제약을 예의주시하고 있다고 공식 발표함. 또한 이 사례를 계기로 2026년 6월 말까지 제약·바이오 기업 공시 가이드라인을 발표할 계획이며, 10% 이상의 주가 변동이 예상됨.

Related Recent Events

View Full Timeline